ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/06/13 | 2,060 | 2,064 | 2,023 | 2,038 | -30 | -1.5% | 98,500 |
2025/06/12 | 2,068 | 2,076 | 2,057 | 2,068 | -3 | -0.1% | 60,400 |
2025/06/11 | 2,068 | 2,092 | 2,068 | 2,071 | +10 | +0.5% | 73,000 |
2025/06/10 | 2,056 | 2,066 | 2,050 | 2,061 | +1 | ±0% | 62,500 |
2025/06/09 | 2,055 | 2,069 | 2,051 | 2,060 | +14 | +0.7% | 51,700 |
2025/06/06 | 2,060 | 2,060 | 2,044 | 2,046 | -10 | -0.5% | 56,000 |
2025/06/05 | 2,065 | 2,079 | 2,054 | 2,056 | -17 | -0.8% | 75,200 |
2025/06/04 | 2,092 | 2,098 | 2,068 | 2,073 | -19 | -0.9% | 105,000 |
2025/06/03 | 2,130 | 2,130 | 2,087 | 2,092 | -51 | -2.4% | 113,600 |
2025/06/02 | 2,155 | 2,174 | 2,136 | 2,143 | -32 | -1.5% | 123,500 |
2025/05/30 | 2,162 | 2,184 | 2,157 | 2,175 | -2 | -0.1% | 141,500 |
2025/05/29 | 2,170 | 2,189 | 2,162 | 2,177 | +12 | +0.6% | 93,300 |
2025/05/28 | 2,156 | 2,174 | 2,148 | 2,165 | +12 | +0.6% | 80,900 |
2025/05/27 | 2,146 | 2,167 | 2,140 | 2,153 | +13 | +0.6% | 56,800 |
2025/05/26 | 2,137 | 2,148 | 2,123 | 2,140 | +3 | +0.1% | 56,600 |
2025/05/23 | 2,114 | 2,142 | 2,105 | 2,137 | +23 | +1.1% | 81,100 |
2025/05/22 | 2,105 | 2,119 | 2,086 | 2,114 | -5 | -0.2% | 63,900 |
2025/05/21 | 2,133 | 2,140 | 2,114 | 2,119 | -6 | -0.3% | 50,300 |
2025/05/20 | 2,167 | 2,167 | 2,125 | 2,125 | -21 | -1% | 49,000 |
2025/05/19 | 2,125 | 2,149 | 2,122 | 2,146 | +6 | +0.3% | 66,100 |
2025/05/16 | 2,124 | 2,154 | 2,120 | 2,140 | +9 | +0.4% | 48,500 |
2025/05/15 | 2,128 | 2,136 | 2,120 | 2,131 | -17 | -0.8% | 47,500 |
2025/05/14 | 2,174 | 2,174 | 2,121 | 2,148 | -16 | -0.7% | 63,300 |
2025/05/13 | 2,204 | 2,210 | 2,150 | 2,164 | -8 | -0.4% | 79,500 |
2025/05/12 | 2,175 | 2,194 | 2,140 | 2,172 | -4 | -0.2% | 122,300 |
2025/05/09 | 2,229 | 2,268 | 2,176 | 2,176 | -153 | -6.6% | 323,400 |
2025/05/08 | 2,360 | 2,367 | 2,301 | 2,329 | -9 | -0.4% | 78,300 |
2025/05/07 | 2,329 | 2,343 | 2,311 | 2,338 | -5 | -0.2% | 44,300 |
2025/05/02 | 2,342 | 2,357 | 2,322 | 2,343 | -6 | -0.3% | 84,900 |
2025/05/01 | 2,343 | 2,378 | 2,332 | 2,349 | +9 | +0.4% | 55,300 |
2025/04/30 | 2,300 | 2,345 | 2,299 | 2,340 | +37 | +1.6% | 57,200 |
2025/04/28 | 2,310 | 2,327 | 2,292 | 2,303 | -7 | -0.3% | 52,400 |
2025/04/25 | 2,340 | 2,345 | 2,302 | 2,310 | -15 | -0.6% | 33,200 |
2025/04/24 | 2,346 | 2,346 | 2,313 | 2,325 | -17 | -0.7% | 32,200 |
2025/04/23 | 2,339 | 2,351 | 2,333 | 2,342 | +8 | +0.3% | 56,300 |
2025/04/22 | 2,315 | 2,337 | 2,297 | 2,334 | +22 | +1% | 38,500 |
2025/04/21 | 2,299 | 2,315 | 2,284 | 2,312 | +8 | +0.3% | 30,000 |
2025/04/18 | 2,279 | 2,309 | 2,271 | 2,304 | +52 | +2.3% | 47,800 |
2025/04/17 | 2,263 | 2,266 | 2,239 | 2,252 | -12 | -0.5% | 28,600 |
2025/04/16 | 2,233 | 2,264 | 2,227 | 2,264 | +31 | +1.4% | 37,500 |
2025/04/15 | 2,255 | 2,260 | 2,222 | 2,233 | -14 | -0.6% | 43,200 |
2025/04/14 | 2,228 | 2,255 | 2,214 | 2,247 | +63 | +2.9% | 45,000 |
2025/04/11 | 2,205 | 2,213 | 2,160 | 2,184 | -58 | -2.6% | 69,500 |
2025/04/10 | 2,233 | 2,249 | 2,188 | 2,242 | +109 | +5.1% | 84,400 |
2025/04/09 | 2,192 | 2,192 | 2,115 | 2,133 | -63 | -2.9% | 100,500 |
2025/04/08 | 2,151 | 2,200 | 2,122 | 2,196 | +59 | +2.8% | 86,600 |
2025/04/07 | 2,079 | 2,162 | 2,065 | 2,137 | -92 | -4.1% | 92,500 |
2025/04/04 | 2,279 | 2,279 | 2,194 | 2,229 | -40 | -1.8% | 89,600 |
2025/04/03 | 2,223 | 2,269 | 2,220 | 2,269 | +11 | +0.5% | 87,300 |
2025/04/02 | 2,279 | 2,294 | 2,249 | 2,258 | -39 | -1.7% | 55,100 |
1~
50
件表示中 / 3720件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,800円 | +3.1% | -6.5% | 2.36% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
科研薬 | 385,500円 | -6.4% | -71.8% | 4.93% | 42.93倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 295,900円 | +7.9% | -3.3% | 2.70% | 8.23倍 | 0.85倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
持田薬 | 294,500円 | +5.1% | -7.0% | 2.72% | 19.33倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 148,300円 | -2.4% | -52.3% | 3.84% | 17.75倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム